Novo Nordisk has reported the second phase 3 trial of its new obesity hopeful CagriSema but, as with the first, the topline weight-loss result has sent its shares into a sharp decline. The stock ...

Novo Nordisk has asked the FDA to stop compounding pharmacies making cheaper versions of its semaglutide-based therapies for obesity and diabetes, saying the drug is too complex to be made safely ...

Drawing its highest attendance ever, the third annual event celebrated the accomplishments of seven business leaders in Greater Grand Forks. The business entrepreneurs who were honored during the ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

GRAND FORKS — A Grand Forks-based company has been recognized by the Evergreen Supply Network as a member of the year. Acme Tools was recognized as a Tier 1 2024 Distributor Member of the Year.

SIOUX FALLS, S.D. — Soybean producers are looking to decrease acres this year, due to the current state of lower soybean prices. According to the United States Department of Agriculture, farmers ...

One of this year's best cooling mattresses should be on every hot sleeper's shopping list right now if you want to bag quality ZZZs this spring and summer. You're probably here because you're fed ...

Two-dimensional materials are substances with a thickness of a few nanometres or less. Electrons in these materials are free to move in the two-dimensional plane, but their restricted motion in ...

Novo's obesity therapy Wegovy is significantly expanding the obesity treatment market given its strong efficacy and is poised to remain a key drug in the market until patent expiration in 2032.